Related Experiment Video
Updated: Jul 16, 2026
08:26
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
Laparoscopic surgery for Crohn's disease: a meta-analysis.
1Department of Colorectal Surgery, Royal Melbourne Hospital and Epworth Colorectal Centre, Melbourne, Australia.
Diseases of the Colon and Rectum
|March 24, 2007
Summary
Laparoscopic surgery for Crohn's disease is safe and feasible. While it takes longer, patients experience faster recovery, shorter hospital stays, and lower morbidity compared to open surgery, with similar recurrence rates.
Area of Science:
- Gastroenterology
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Crohn's disease is a chronic inflammatory bowel condition requiring surgical intervention for complications.
- Laparoscopic surgery offers potential benefits over traditional open procedures, including reduced invasiveness.
Purpose of the Study:
- To evaluate the safety and feasibility of laparoscopic surgery for patients with Crohn's disease.
- To compare short-term outcomes of laparoscopic versus open surgical approaches in Crohn's disease management.
Main Methods:
- A comprehensive literature search was conducted using MEDLINE, PubMed, and Cochrane Central Register of Controlled Trials (January 1990–February 2006).
- Studies were independently reviewed, and meta-analysis with Forest plots was performed for available raw data, means, and standard deviations.
Main Results:
- Laparoscopic surgery had an 11.2% conversion rate to open surgery.
- Procedures were longer (mean difference 25.54 minutes, P=0.03), but resulted in faster bowel function recovery (0.75 days, P=0.02) and earlier oral intake (1.43 days, P=0.0008).
- Hospitalization was shorter (1.82 days, P=0.02), and morbidity was significantly lower (OR 0.57, P=0.01) with similar disease recurrence rates compared to open surgery.
Conclusions:
- Laparoscopic surgery for Crohn's disease demonstrates significant short-term patient benefits, including reduced morbidity and shorter recovery times.
- Despite longer operative times, laparoscopic surgery is deemed safe and feasible for Crohn's disease management.
- The comparable disease recurrence rates support the adoption of laparoscopic techniques in Crohn's disease surgery.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...